limited to cell migration during inflammation tissue remodeling wound healing tumor cell invasion and metastasis skeletal myogenesis neurite outgrowth plasminogen receptors also modulate apoptosis and cell death the invention also relates to antibodies that inhibit plasminogen plasminogen fragments such as angiostatin 1 and other plasminongen fragments having angiostatic activity tissue plasminogen activator or lipoprotein binding to plg r kt and or immunoreact with plg r kt application_number US 201213653862 A description amino acid residue the amino acid residues described herein are preferred to be in the u201c l u201d isomeric form however residues in the u201c d u201d isomeric form can be substituted for any l amino acid residue as long as the desired functional property is retained by the polypeptide nh 2 refers to the free amino group present at the amino terminus of a polypeptide cooh refers to the free carboxy group present at the carboxy terminus of a polypeptide in keeping with standard polypeptide nomenclature j biol chem 243 3552 59 1969 abbreviations for amino acid residues are shown in the following table of correspondence it should be noted that all amino acid residue sequences are represented herein by formulas whose left and right orientation is in the conventional direction of amino terminus to carboxy terminus furthermore it should be noted that a dash at the beginning or end of an amino acid residue sequence indicates either a peptide bond to a further sequence of one or more amino acid residues or a covalent bond to a carboxyl or hydroxyl end group the absence of a dash indicates a polyeptide with no additional amino acid residues other than those specified antibody the term antibody in its various grammatical forms is used herein.